Clinical Trials on Castrate-resistant Metastatic Prostate Cancer
Total 10899 results
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
BayerCompletedMetastatic Castration-Resistant Prostate CancerSweden
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, IncActive, not recruitingProgressive Disease | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Adenocarcinoma | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation... and other conditionsUnited States
-
Duke UniversityUnited States Department of Defense; Prostate Cancer Foundation; Janssen Diagnostics...CompletedMetastatic Progressive Castration-resistant Prostate Cancer | Metastatic Progressive Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
POINT Biopharma, a wholly owned subsidiary of Eli...Eli Lilly and CompanyRecruitingProstate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerCanada
-
University of WashingtonNational Cancer Institute (NCI); Prostate Cancer FoundationTerminatedRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of California, DavisSanofiTerminatedHormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Hansoh BioMedical R&D CompanyRecruitingMetastasis Castration Resistant Prostate Cancer(mCRPC)China
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate CancerBelgium
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Hormone-Resistant Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingCastration-Resistant Prostate CancerChina
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Technical University of MunichRecruitingCastration-resistant Prostate CancerGermany
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Donald Trump, MDTerminated
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Castration-Resistant Prostate CancerRussian Federation, Georgia
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Seattle Institute for Biomedical and Clinical ResearchVA Puget Sound Health Care System; Prostate Cancer FoundationTerminatedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownCastration-resistant Prostate Cancer
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
University of Michigan Rogel Cancer CenterRecruitingProstate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate CancerUnited States
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.TerminatedMetastatic Disease | Castration-Resistant Prostatic CancerUnited States
-
Providence Health & ServicesMedImmune LLCCompletedProstate Cancer | Metastatic Prostate Cancer | Cancer of the ProstateUnited States
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompletedCastration-resistant Prostate CancerNetherlands
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedProstate Cancer | Castration-resistant Prostate CancerChina
-
SOTIO a.s.TerminatedCastration-resistant Prostate CancerCzechia
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States